FDA EXPORT REGULATIONS SHOULD BE CHANGED LEGISLATIVELY TO REDUCE MANUFACTURING FLIGHT OVERSEAS, AMGEN CHAIRMAN BINDER TELLS HOUSE OVERSIGHT SUBCOMMITTEE
Executive Summary
Elimination of FDA export restrictions via the legislative process would help reduce the relocation of U.S. manufacturing facilities overseas, Amgen Chairman Gordon Binder maintained at a May 25 House Commerce/Oversight Subcommittee hearing on FDA reform.